Replies to post #85511 on Amarantus Bioscience Holdings Inc (AMBS)

[JPetroInc]

would this be the "wonderful omlette" pre-egg cracking or post-egg cracking assertion

but it also shows that those deals have not materialized as of yet

in all fairness to you, you could be right - but then you would have to ask yourself - if LymPro's assay testing w/BD went terribly wrong, would Dr. Rubenfield and the current BOD and Owners be placing their own $ into another tranche. My answer would be emphatically "no"

[MUKA1]

From our perspective, we want the big pharma deal to reaffirm our investment and belief in AMBS...and to drive away the nay-sayers buzzing around....and see the pps climb.

From a business perspective, if you have the $$ available, wouldn't it make more sense to further develop and prove the product so that you can then ask for a larger deal? I would think this is especially true of MANF, given the huge disappointments observed with GDNF this year..